Abstract:Curcumin (CUR) has attracted wide research interests due to its abundant bioactivities and potential advantages in cancer treatment. But the poor water solubility, instability, and quick metabolization and elimination after oral administration severely restrict the efficacy and further clinical application of CUR. Derivation is an approach often used to improve the druggability of active ingredients, so the study aim to prepare a CUR derivate with better stability, satisfactory pharmacokinetics, and inherent self-assembled ability in contrast with CUR. The derivate was designed and evaluated in vitro and in vivo. Vitamin E (VE) was used to perform the esterification reaction with CUR, and the cytotoxicity of derivative CUR-VE ester on MCF-7 tumor cells was similar to CUR. Besides the better stability in simulated gastric and intestinal fluid, plasma and liver homogenate, the self-assembly CUR-VE nanoparticles were fabricated by feasible and controllable nanoprecipitation method. The Transmission Electron Microscope (TEM) showed CUR-VE NPs were spherical with an average particle size of 172.9 nm, and drug loading was up to 93%. CUR-VE NPs exhibited a sustained-release behavior and fitted to Fick's diffusion mechanism. Differential Scanning Calorimeter (DSC), X-ray Powder Diffractometer (XRPD) and Fourier Transform Infrared Spectrometer (FTIR) declared no crystalline substances were formed, and the self-assembly process of CUR-VE relied on driving forces including van der Waals forces, hydrogen bonding forces, intermolecular forces. In pharmacokinetics, Cmax and AUC0-∞ of CUR-VE NPs by the route of oral administration were (104.69 ± 40.72) ng/mL and (3496.92 ± 1088.93) ng/mL*h, which were about three times and 18 times more compared with CUR. The eliminated half-time of CUR-VE extended to 28 h ascribed to the outstanding stability and surface PEGylation of NPs. It prompted that appropriately PEGylated NPs via oral administration was beneficial to prolong systemic circulation similar to intravenous PEGylated NPs.In summary, the study provides a convenient way to fabricate the self-assembled CUR-VE NPs qualified with high drug loading, satisfactory stability and desired pharmacokinetics. CUR-VE has the potent advantage to be an ideal substitute for CUR in the future of healthcare and clinical application.

Enhanced oral bioavailability of self-assembling curcumin-vitamin E prodrug-nanoparticles by co-nanoprecipitation with vitamin E TPGS

Excogitation and Assessment of Curcumin-Vitamin E Self-assembly PEGylated Nanoparticles by the Route of Oral Administration

Glutathione-sensitive PEGylated Curcumin Prodrug Nanomicelles: Preparation, Characterization, Cellular Uptake and Bioavailability Evaluation

Glutathione-responsive Self-Delivery Nanoparticles Assembled by Curcumin Dimer for Enhanced Intracellular Drug Delivery

Preparation, Characterization, Pharmacokinetics, and Tissue Distribution of Curcumin Nanosuspension with Tpgs As Stabilizer

Enhanced Oral Delivery of Curcumin Via Vitamin E TPGS Modified Nanodiamonds: a Comparative Study on the Efficacy of Non-covalent and Covalent Conjugated Strategies

Study on the Stability and Oral Bioavailability of Curcumin Loaded (-)-epigallocatechin-3-gallate/poly(n-vinylpyrrolidone) Nanoparticles Based on Hydrogen Bonding-Driven Self-Assembly

Functionalization of Nanodiamond with Vitamin E TPGS to Facilitate Oral Absorption of Curcumin

Curcumin-tannic acid-poloxamer nanoassemblies enhance curcumin's uptake and bioactivity against cancer cells in vitro

Toxicity Reduction and Efficacy Promotion of Doxorubicin in the Treatment of Breast Tumors Assisted by Enhanced Oral Absorption of Curcumin-Loaded Lipid-Polyester Mixed Nanoparticles.

The Enhancement of N-acetylcysteine on Intestinal Absorption and Oral Bioavailability of Hydrophobic Curcumin.

Preparation and in vivo pharmacokinetics of curcumin-loaded PCL-PEG-PCL triblock copolymeric nanoparticles.

Cationic Curcumin Nanocrystals Liposomes for Improved Oral Bioavailability: Formulation Development, Optimization, In Vitro and In Vivo Evaluation

Enhanced bioavailability of curcumin amorphous nanocomposite prepared by a green process using modified starch

BSA Nanoparticles Modified with N -Acetylcysteine for Improving the Stability and Mucoadhesion of Curcumin in the Gastrointestinal Tract.

Preparation and In-Vitro/in-vivo Evaluation of Curcumin Nanosuspension with Solubility Enhancement.

Preparation of curcumin-loaded chitosan/lecithin nanoparticles with increased anti-oxidant activity and in vivo bioavailability

Investigations on the Interactions Between Curcumin Loaded Vitamin E TPGS Coated Nanodiamond and Caco-2 Cell Monolayer

Enhancement of Curcumin Bioavailability by Encapsulation in Sophorolipid-Coated Nanoparticles: an in Vitro and in Vivo Study.

Enhanced stability and dissolution of curcumin nanocrystals stabilized by octenyl succinic anhydride modified starch

Advances in Curcumin-Loaded Nanopreparations: Improving Bioavailability and Overcoming Inherent Drawbacks